NCT01332825
- Conditions
- Anosmia, Nervous System Diseases, Neurologic Manifestations, +5 more
- Locations
-
- University of Washington Seattle, Washington, United States
Clinical trial condition
Anosmia
Explore clinical trials studying Anosmia. Study availability and eligibility vary by location and protocol.
131 public trials
19 recruiting studies
Anosmia trial results
NCT00553384
- Conditions
- Anosmia, Healthy, Nervous System Diseases, +5 more
- Locations
-
- The Rockefeller University Hospital New York, United States
NCT00902941
- Conditions
- Anosmia, Basal Ganglia Diseases, Brain Diseases, +13 more
- Locations
-
- University of Dresden Medical School, Smell & Taste Centre, Dept. of Neurology Dresden, Germany
NCT00097253
- Conditions
- Anosmia, Anxiety, Anxiety Disorders, +11 more
- Locations
-
- Ohio State University Institute for Biobehavioral Medicine Research Columbus, Ohio, United States
Active, Not Recruiting
The Brain&Senses Study
NCT06991816
- Conditions
- Alzheimer Disease, Anosmia, Brain Diseases, +20 more
- Locations
-
- Vanvitelli ENT department Naples, Campania, Italy
Active, Not Recruiting
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
NCT05040659
- Conditions
- Anosmia, Asymptomatic COVID-19, COVID-19, +28 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
Treatment of Olfactory Dysfunction Using Vagus Nerve Stimulation
NCT06817499
- Conditions
- Anosmia, Hyposmia, Nervous System Diseases, +5 more
- Locations
-
- Karolinska Institutet Solna, Stockholm County, Sweden
Active, Not Recruiting
Mechanical and Sensorial Training in the Olfactive Rehabilitation of Patients With Total Laryngectomy
NCT07122037
- Conditions
- Anosmia, Cognitive Aging, Hyposmia, +7 more
- Locations
-
- CHU UCL Namur Site Godinne Yvoir, Belgium
Active, Not Recruiting
Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
NCT06204432
- Conditions
- Anosmia, COVID-19, Chronic Disease, +22 more
- Locations
-
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
Active, Not Recruiting
Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™
NCT04507139
- Conditions
- Anosmia, Basal Ganglia Diseases, Brain Diseases, +12 more
- Locations
-
- Institute For Neurodegenerative Disorders New Haven, Connecticut, United States
- Boston University Medical Center Boston, Massachusetts, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States